The syndrome of cardiogenic shock has been defined as the inability of the heart -- as a result of impairment of its pumping function -- to deliver sufficient blood flow to the tissues to meet ...

SGMC Health has successfully performed its first procedure using the Abiomed Impella 5.5 with SmartAssist, a minimally ...

Istaroxime has previously completed two positive Phase 2 studies in SCAI Stage B cardiogenic shock; the SEISMiC C study in SCAI Stage C cardiogenic shock is another step progressing to the istaroxime ...

Following discharge for COVID-19 hospitalization, county-level social deprivation does not affect long-term cardiovascular risk.

According to the Ministry of Health and Family Welfare, the number of active cases increased by 276 in the last 24 hours, ...

Despite advances in the treatment of myocardial infarction (MI), the incidence of cardiogenic shock has remained at 7% to 10% during the last 25 years. Hospital mortality was about 90% in the ...